Webster Bank’s Abeona Therapeutics ABEO Stock Holding History

Webster Bank’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	–	–	531
2022 Q1	$0	Hold	3	–	–	﹤0.01%	537
2021 Q4	$0	Hold	3	–	–	﹤0.01%	543
2021 Q3	$0	Hold	3	–	–	﹤0.01%	536
2021 Q2	$0	Hold	3	–	–	﹤0.01%	521
2021 Q1	$0	Hold	3	–	–	﹤0.01%	540
2020 Q4	$0	Hold	3	–	–	﹤0.01%	534
2020 Q3	$0	Hold	3	–	–	﹤0.01%	515
2020 Q2	$0	Buy	+3	New	+$207	﹤0.01%	506

Other funds holding ABEO

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Webster Bank's ABEO Position: Q2 2022 in Review

Webster Bank sold out of Abeona Therapeutics (ABEO) in Q2 2022, closing a stake of 3 shares.

Webster Bank first reported a position in ABEO in Q2 2020 and held it in 8 quarters. The position peaked at $0 in Q1 2022. 42 funds tracked by Wall St. Rank hold ABEO as of Q2 2022.

Webster Bank reported no remaining Abeona Therapeutics position as of Q2 2022 after selling out during the quarter.
Webster Bank sold 3 Abeona Therapeutics shares in Q2 2022.
Webster Bank first reported a position in Abeona Therapeutics in Q2 2020 and held it in 8 quarters.
Webster Bank's Abeona Therapeutics position peaked at $0 in Q1 2022.
42 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2022.

Based on Webster Bank's 13F filing for Q2 2022, filed 12 Jul 2022.